ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $59,330,690 | -36.2% | 18,716,306 | 0.0% | 1.02% | -25.0% |
Q2 2023 | $93,020,041 | +0.6% | 18,716,306 | 0.0% | 1.37% | -9.4% |
Q1 2023 | $92,458,552 | -21.5% | 18,716,306 | 0.0% | 1.51% | -34.8% |
Q4 2022 | $117,725,565 | -41.8% | 18,716,306 | 0.0% | 2.31% | -30.2% |
Q3 2022 | $202,136,000 | -5.3% | 18,716,306 | 0.0% | 3.31% | +0.4% |
Q2 2022 | $213,366,000 | +25.1% | 18,716,306 | 0.0% | 3.30% | +56.4% |
Q1 2022 | $170,506,000 | -38.9% | 18,716,306 | 0.0% | 2.11% | -24.4% |
Q4 2021 | $279,247,000 | – | 18,716,306 | – | 2.79% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $46,213,000 | 13.24% |
Wildcat Capital Management, LLC | 1,716,370 | $44,111,000 | 5.71% |
TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $481,009,000 | 4.77% |
Copernicus Capital Management, LLC | 15,000 | $386,000 | 4.67% |
Coastal Bridge Advisors, LLC | 301,240 | $7,742,000 | 1.79% |
Lombard Odier Asset Management (Switzerland) SA | 914,416 | $23,500,000 | 1.46% |
Casdin Capital, LLC | 2,100,000 | $53,970,000 | 1.34% |
Pier Capital, LLC | 450,182 | $11,570,000 | 1.20% |
Ghost Tree Capital, LLC | 150,000 | $3,855,000 | 1.13% |
Sessa Capital IM, L.P. | 750,000 | $19,275,000 | 0.95% |